StockWatch
·

Eris Lifesciences Ltd Q3 FY25 Results

ERISQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue727.451.6%
Total Income731.671.9%
Expenditure615.510.2%
PBT116.1610.0%
Net Profit86.939.8%
OPM-3.63%1.25pp
NPM11.88%1.04pp
EPS6.158.6%
View full financials

Informational and educational content only. Not investment advice.